Glenn M. Chertow on Muck Rack

Glenn M. Chertow

As seen in: Color Research & Application, Nature, Wiley Online Library, PLOS Medicine, JAMA (The Journal of the American Medical Association), JAMA Health Forum Conversations, Medscape, The New England Journal of Medicine, EClinicalMedicine, Nephrology Dialysis Transplantation and
Stanford University School of Medicine. Views are my own.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Glenn M.

Contact Glenn M., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO

|
By Wolfgang C. Winkelmayer, Susan Arnold, Steven Burke Verified, Glenn M. Chertow
| Texas Medical Center
RATIONALE & OBJECTIVE: Prespecified analyses of the PRO STUDY DESIGN: Phase 3, global, open-label, randomized, active-controlled clinical trial. SETTING AND PARTICIPANTS: Erythropoiesis-stimulating agent-untreated patients with anemia and NDD-CKD. INTERVENTION: Eligible patients were randomized 1:1 to receive vadadustat or darbepoetin alfa. OUTCOMES: The primary safety end point was time to first MACE.
Open in Who Shared Issue with article?

"Market Competition and Anemia Management in the United States Followin" by Anshul Bhatnagar, Vishnupriyadevi Parvathareddy et al.

|
By Anshul Bhatnagar, Vishnupriyadevi Parvathareddy, Wolfgang C. Winkelmayer, Glenn M. Chertow
| Texas Medical Center
BACKGROUND: Whether market competition influences health care provider responses to national reimbursement reforms is unknown. OBJECTIVES: We examined whether changes in anemia management after the expansion of Medicare's dialysis payment bundle varied with market competition.
Open in Who Shared Issue with article?

"Patient Perspectives on Using Telemedicine During In-Center Hemodialys" by Trenton M Haltom, Susie Q Lew et al.

|
By Trenton M. Haltom, Susie Q Lew, Wolfgang C. Winkelmayer, Glenn M. Chertow
| Texas Medical Center
RATIONALE & OBJECTIVE: In the wake of the coronavirus disease 2019 (COVID-19) pandemic, the United States federal government expanded originating telemedicine sites to include outpatient dialysis units. For the first time, nephrology practitioners across the United States could replace face-to-face visits with telemedicine for patients receiving in-center hemodialysis. This study describes patients' perspectives on the use of telemedicine during in-center hemodialysis.
Open in Who Shared Issue with article?
See all 66 licensed articles (68 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified